This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
This article is Part 5 of a review series covering all the initial public offerings for the biotech and pharmaceutical…
Article
8 months ago ●
7 mins read
A metabolite and its parent: same target inhibition, different mechanisms. PF-6870961 is a growth hormone secretagogue receptor 1a (GHSR1a) inverse…
molecule
1 month ago ●
6 mins read
As biotech experts, risk taking is part of our business model. Without scientific and business risk, inventions would not occur…
Article
8 months ago ●
8 mins read
A protein-protein interaction inhibitor for a challenging-to-drug master transcription factor. OICR12694 is an oral protein-protein interaction inhibitor targeting the challenging-to-drug…
molecule
1 month ago ●
5 mins read
In this guest article, Dr. LuÃza Cruz breaks down the synthesis of Gilead’s lenacapavir (GS-6207), Drug Hunter’s Small Molecule of…
Article
8 months ago ●
5 mins read
A first-in-class drug for NASH? Resmetirom, an oral, liver-targeting, once-daily THR-β-selective agonist, recently made headlines for meeting both primary surrogate…
molecule
2 months ago ●
5 mins read
Load More
